Li Zhenhui, Yan Guanghong, Liu Mengmei, Li Yanli, Liu Lizhu, You Ruimin, Cheng Xianshuo, Zhang Caixia, Li Qingwan, Jiang Zhaojuan, Ruan Jinqiu, Ding Yingying, Li Wenliang, You Dingyun, Liu Zaiyi
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Sciences, Guangzhou, China.
Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2519-2535. doi: 10.1002/jcsm.13594. Epub 2024 Oct 3.
The association between perioperative changes in the skeletal muscle index (SMI) and colorectal cancer (CRC) outcomes remains unclear. We aim to explore perioperative change patterns of SMI and evaluate their effects on long-term outcomes in CRC patients.
This retrospective cohort study included Stage I-III CRC patients who underwent curative resection between 2012 and 2019. SMI at the third lumbar vertebra level was calculated using computed tomography scans. Optimal cut-off values for SMI were defined separately for males and females and classified as high or low preoperatively and at 3, 6, 9 and 12 months postoperatively. SMI status was further categorized into different perioperative SMI change patterns: high-high, high-low, low-high and low-low. The association with recurrence-free survival (RFS) and overall survival (OS) was examined using Cox proportional hazards models.
A total of 2222 patients (median [interquartile range] age, 60.00 [51.00-68.00] years; 1302 (58.60%) men; 222 (9.99%) with preoperative low SMI) were evaluated. During a median follow-up of 60 months, 375 patients (16.88%) died, and 617 patients (27.77%) experienced a recurrence. Multivariate Cox model analysis showed that, compared to patients with high-high, those with high-low (HR = 3.32, 95% CI: 1.60-6.51; HR = 2.54, 95% CI: 1.03-6.26; HR = 2.93, 95% CI: 1.19-7.19, all p < 0.05) had significantly worse RFS and OS (HR = 4.07, 95% CI: 1.55-10.69; HR = 4.78, 95% CI: 1.40-16.29; HR = 9.69, 95% CI: 2.53-37.05, all p < 0.05), at postoperative 6, 9 and 12 months, respectively. Patients with low-low were an independent prognostic factor for worse OS at postoperative 12 months (HR = 3.20, 95% CI: 1.06-9.71, p = 0.040). Patients with low-high had similar risk of RFS compared to those with high-high at postoperative 3, 6 and 12 months (HR = 1.49, 95% CI: 0.75-2.98; HR = 1.05, 95% CI: 0.45-2.43; HR = 1.36, 95% CI: 0.31-6.06, all p > 0.05) and similar risk of OS at postoperative 3, 6, 9 and 12 months (all p > 0.05).
Patients with a high preoperative SMI that decline postoperatively have poor RFS and OS. Consistently low SMI also correlates with worse OS. Patients with low SMI but increased after resection are not an indicator of better prognosis. Routine measurement of postoperative, rather than preoperative, SMI is warranted. Patients with low SMI are at an increased risk for recurrence and death, especially within the first year after surgery.
骨骼肌指数(SMI)围手术期变化与结直肠癌(CRC)预后之间的关联尚不清楚。我们旨在探讨SMI围手术期变化模式,并评估其对CRC患者长期预后的影响。
这项回顾性队列研究纳入了2012年至2019年间接受根治性切除术的I-III期CRC患者。使用计算机断层扫描计算第三腰椎水平的SMI。分别为男性和女性定义SMI的最佳截断值,并在术前以及术后3、6、9和12个月将其分为高或低。SMI状态进一步分为不同的围手术期SMI变化模式:高-高、高-低、低-高和低-低。使用Cox比例风险模型检查与无复发生存期(RFS)和总生存期(OS)的关联。
共评估了2222例患者(中位年龄[四分位间距]为60.00[51.00-68.00]岁;1302例(58.60%)为男性;222例(9.99%)术前SMI低)。在中位随访60个月期间,375例患者(16.88%)死亡,617例患者(27.77%)复发。多变量Cox模型分析显示,与高-高模式的患者相比,高-低模式的患者在术后6、9和12个月时RFS和OS显著更差(HR分别为3.32,95%CI:1.60-6.51;HR为2.54,95%CI:1.03-6.26;HR为2.93,95%CI:1.19-7.19,均p<0.05)。低-低模式的患者是术后12个月时OS更差的独立预后因素(HR=3.20,95%CI:1.06-9.71,p=0.040)。低-高模式的患者在术后3、6和12个月时与高-高模式的患者相比RFS风险相似(HR分别为1.49,95%CI:0.75-2.98;HR为1.05,95%CI:0.45-2.43;HR为1.36,95%CI:0.31-6.06,均p>0.05),在术后3、6、9和12个月时OS风险也相似(均p>0.05)。
术前SMI高但术后下降的患者RFS和OS较差。持续低SMI也与较差的OS相关。SMI低但切除后升高的患者并非预后较好的指标。有必要常规测量术后而非术前的SMI。SMI低的患者复发和死亡风险增加,尤其是在术后第一年。